However, the downregulation of key angiogenic inhibitors such as thrombospondin-1 (THBS1) and platelet factor 4 (PF4) suggests a disrupted regulatory balance that may promote unchecked neovascularization within the tumor microenvironment. This evidence concerns the gene THBS1 and neoplasm.